Entering StartUpLand: An Essential Guide to Finding the Right Job

Jeffrey J. Bussgang

Book | 2017

Entering StartUpLand: An Essential Guide to Finding the Right Job

Abstract

Many professionals aspire to work for startups. Executives from large companies view them as models to help them adapt to today's dynamic innovation economy, while freshly minted MBAs see magic in founding something new. Yes, startups look magical, but they can also be chaotic and inaccessible. Many books are written for those who aspire to be founders, but a company only has one or two of those. What's needed is something that deconstructs the typical startup organization for the thousands of employees who join a fledgling company and do the day-to-day work required to grow it into something of value. Entering StartUpLand is a practical, step-by-step guide that provides an insider's analysis of various startup roles and responsibilities—including product management, marketing, growth, and sales—to help you figure out if you want to join a startup and what to expect if you do. You'll gain insight into how successful startups operate and learn to assess which ones you might want to join—or emulate. Inside this book you'll find 1) a tour of typical startup roles to help you determine which one might be the best fit for you, 2) profiles of startup executives across many different functions who share their stories and describe their responsibilities, and 3) a methodology to identify and evaluate startups and position yourself to find the opportunity that's right for you. Entering StartUpLand will guide you as you seek your ideal entry point into this popular, cutting-edge organizational paradigm.

Keywords: Business Startups; Managerial Roles; Job Search;

Format: Print

Find at Harvard Purchase

Citation:

Bussgang, Jeffrey J. Entering StartUpLand: An Essential Guide to Finding the Right Job. Boston: Harvard Business Review Press, 2017.

Laura Behrens Wu, CEO of software start-up Shippo, prepares her pitch for a Series A funding round following a successful seed round. Customer adoption of Shippo’s e-commerce dashboard application, which allows small and medium retailers to compare delivery rates between shipping providers and print package labels, has been steady in the nine months since it went live. But traction with the firm’s developer friendly product, an API that allows large enterprise customers to automate their shipping needs, had initially been slow until one customer single handedly tripled the API label volume in late August. Now in November 2014, with nine months of runway remaining, Behrens Wu must decide where to direct the company’s limited resources. Should Shippo stay focused on the app while raising the next round of funding, pivot to an API-focused strategy, or pursue both products?

In late 2016, Paris Wallace, the CEO of Ovia Health, and the rest of the company’s co-founders faced a difficult decision about the best way to grow Ovia Health’s revenue. Founded in 2012, Ovia Health specialized in mobile and web applications in the women’s health space. After building a strong user base with its original app (Ovia Fertility, which helped women conceive by tracking ovulation and other factors), the young company launched a second app, Ovia Pregnancy, which helped women have a healthy pregnancy by tracking various health metrics. Ovia Health’s apps were free to use, and most of the company’s revenue came from charging advertisers to host ads on its native advertising platform. Wallace believed that the family benefits market was a promising growth area, but he was not sure of the best way to enter the market. Recently, a top health benefits provider had offered Ovia Health a multi-million-dollar contract, but Wallace wondered whether Ovia Health could create a better family benefits solution by turning down the contract and selling directly to employers’ HR departments. Participants will need to examine how Ovia Health evolved its strategy over time and decide which growth opportunity was the better choice.

In March 2020, as COVID-19 spreads rapidly across the U.S., Everlywell founder Julia Cheek considers how to respond as a small start-up specializing in at-home lab testing. After making dramatic budget cuts, she decides to pivot the organization to address the country’s testing shortage. But after a hectic few weeks building capacity at her partner labs to 30,000 COVID daily tests, the U.S. Food and Drug Administration (FDA) releases a statement warning the public that it has not granted approval for at-home tests. Cheek must decide whether to return to her core business or persist in focusing her nascent organization on COVID-19 tests, an opportunity whose commercial merit is unclear.

Faculty & Research

Entering StartUpLand: An Essential Guide to Finding the Right Job

Abstract

Citation:

About the Author

More from the Author